Vitamin B6 Deficiency: Skin, Nerve, and Anemia Signs

Vitamin B6 deficiency disrupts a surprisingly wide range of bodily functions because the vitamin’s active form serves as a helper molecule for more than 140 enzymes, many of them involved in building neurotransmitters, making hemoglobin, and running the immune system. Mild deficiency is more common than most people realize, and it can show up in ways that mimic other conditions, from tingling in the hands and feet to unexplained rashes or stubborn anemia. The causes extend well beyond a poor diet, which is part of why the deficiency often goes unrecognized.

What Vitamin B6 Actually Does

The body converts the various forms of vitamin B6 you get from food into an active coenzyme called pyridoxal 5′-phosphate, usually shortened to PLP. PLP is involved in more than 140 enzymatic reactions, with the largest share centered on amino acid metabolism, the process of building, breaking down, and recycling proteins.¹ That alone would make it important, but PLP also plays direct roles in synthesizing neurotransmitters like serotonin, dopamine, norepinephrine, and GABA. It contributes to hemoglobin production, helps regulate homocysteine levels in the blood, and supports the proliferation and differentiation of immune cells. When PLP levels drop, none of these systems stop working overnight, but all of them start to falter.

How Deficiency Shows Up on the Skin

One of the more visible signs of B6 deficiency is a distinctive set of skin and mouth changes. Angular cheilitis, the cracking and inflammation at the corners of the mouth, is a classic presentation, often alongside glossitis, a swollen and sore tongue. In more severe cases, people develop a diffuse, painful, blistering rash that can be mistaken for other dermatological conditions. A case report following a patient who had undergone gastric bypass surgery documented critically low serum levels of both zinc and vitamin B6, with angular cheilitis, glossitis, and a widespread painful rash that slowly improved over two weeks once oral supplementation began.² The overlap with zinc deficiency in that case is telling: the skin symptoms of multiple micronutrient deficiencies look similar, and after bariatric surgery, patients frequently run low on several nutrients at once. That makes it easy for B6 deficiency to hide behind another diagnosis.

Nerve Damage and Neurological Effects

Because B6 is essential for producing the neurotransmitters that keep the nervous system running, deficiency can cause peripheral neuropathy, damage to the nerves in your hands, feet, and limbs. The sensations are often described as numbness, tingling, or burning, and the damage tends to be axonal, meaning the long fibers of the nerve cells themselves degrade rather than just their insulating coating. A systematic review examining B6 and peripheral neuropathy found that patients with low pyridoxal levels had significantly lower nerve function measurements compared to healthy controls, and the neuropathy was axonal in most cases.³

The neurological effects are not limited to the peripheral nerves. Because B6 is a cofactor for producing GABA, the brain’s primary inhibitory neurotransmitter, severe deficiency can lower the seizure threshold. In adults, this rarely leads to outright seizures, but in infants and young children, the consequences can be dramatic, as discussed in the section on genetic conditions below.

A Type of Anemia You Might Not Expect

Most people associate anemia with iron deficiency, but B6 deficiency can cause its own form. PLP is a required coenzyme for delta-aminolevulinic acid synthase, the enzyme that kicks off the production of heme, the iron-carrying component of hemoglobin. When B6 is insufficient, heme synthesis stalls even if iron is plentiful, and iron accumulates inside red blood cell precursors in a ring pattern around the cell’s nucleus. The resulting condition, called sideroblastic anemia, produces small, pale red blood cells and can look a lot like iron-deficiency anemia on standard blood tests.

In one reported case, a 49-year-old man was initially diagnosed with myelodysplastic syndrome, a type of bone marrow cancer, based on his severe microcytic anemia and ringed sideroblasts. His B6 deficiency turned out to be caused by long-term use of the antidepressant amoxapine, and his blood counts improved after B6 supplementation and discontinuation of the medication.⁴ That case is a useful reminder: sideroblastic anemia from B6 deficiency is treatable, but only if someone thinks to test for it.

Who Is Most Likely to Become Deficient

Diet alone is rarely the whole story. Most Western diets contain enough B6 from poultry, fish, potatoes, and fortified cereals to meet the recommended daily amount of around 1.3 to 1.7 milligrams for adults. The more common problem is that certain medical conditions and medications accelerate B6 loss or block its conversion to the active PLP form.

Alcohol Use

Chronic alcohol consumption is one of the best-studied causes of B6 depletion. The mechanism is not simply that heavy drinkers eat poorly, though that contributes. When the liver metabolizes ethanol, the resulting byproduct acetaldehyde accelerates the breakdown of intracellular PLP. Research has shown that this effect depends specifically on ethanol oxidation: blocking the enzyme that starts the process with an inhibitor abolished the PLP-degrading effect entirely.⁵ In other words, every drink actively destroys PLP in the liver, regardless of how much B6 a person consumes in food.

Chronic Kidney Disease and Dialysis

People with chronic kidney disease are at strikingly high risk. A systematic review covering studies from 2000 to 2010 found that B6 deficiency was present in roughly a quarter to over half of hemodialysis patients, and the dialysis procedure itself reduced plasma B6 levels by 28 to 48 percent per session depending on the type of membrane used.⁶ Modern treatments for kidney disease, including erythropoietin-stimulating agents and certain phosphate-binding medications, appear to worsen the problem further.

The underlying mechanism seems to involve a metabolic pathway called transsulfuration, which uses B6 as a cofactor. Research on hemodialysis patients found that baseline B6 levels were dramatically lower in dialysis patients compared to controls, and that even after homocysteine levels were brought down with treatment, another amino acid in the same pathway remained elevated, suggesting persistent overactivation of B6-dependent reactions that drain the body’s supply.⁷ A separate study of end-stage renal disease patients confirmed universal B6 deficiency in the group and noted that the problem did not appear to stem from poor absorption. Instead, abnormally high levels of a B6 breakdown product suggested that something about kidney failure accelerates B6 destruction internally.⁸

Liver Disease

Severe liver disease creates its own set of problems. The liver is where pyridoxine from food gets phosphorylated into PLP. When the liver is damaged, this conversion is impaired. Studies of patients with chronic liver disease found that when standard pyridoxine hydrochloride supplements were given intravenously, only about a third of patients showed an increase in plasma PLP. Those who responded least also excreted the most 4-pyridoxic acid, a breakdown product of PLP, suggesting that even the PLP their liver managed to produce was being degraded at an unusually high rate.⁹ For clinicians, this means that standard B6 supplements may not work for patients with advanced liver damage, and giving the already-active PLP form directly may be more effective.

Oral Contraceptives

Long-term use of oral contraceptives has been linked to lower B6 status for decades. A study comparing pregnant women who had used oral contraceptives for more than 30 months before conception with short-term users and nonusers found that the long-term group had significantly lower B6 levels in maternal serum at five months of pregnancy and at delivery, as well as lower levels in their breast milk and in cord blood at birth.¹⁰ The clinical relevance of this varies, since modern oral contraceptives contain lower hormone doses than those used in older studies. But for women who take hormonal contraception for years and then become pregnant, it is worth being aware that their B6 reserves may start out lower than expected.

The B6 Paradox: When Supplements Mimic Deficiency

Here is something that catches a lot of people off guard: taking too much B6 in supplement form can produce symptoms that look almost identical to B6 deficiency. Since 2014, more than 50 cases of sensory nerve pain attributed to B6 supplementation have been reported.¹¹ The explanation involves the difference between the inactive form of B6, pyridoxine, which is the form found in most supplements, and the active coenzyme PLP. At high doses, pyridoxine floods the system and competitively blocks PLP from binding to the enzymes that need it. The result is a functional B6 deficiency created by an excess of the vitamin itself.

This paradox matters practically. People experiencing unexplained tingling, burning, or numbness who suspect a nutrient deficiency may reach for a B6 supplement, and if the dose is high enough, they can make the problem worse. The tolerable upper intake level for adults is set at 100 milligrams per day, but some supplements on the market exceed that. The neuropathy from excess B6 is usually reversible once supplementation stops, but recovery can take months.

How Deficiency Is Diagnosed

Diagnosing B6 deficiency is not as straightforward as running a single blood test. The most commonly used measure is plasma PLP concentration, and a level below about 20 nanomoles per liter is generally considered deficient. But PLP alone does not tell the full story. Inflammation can temporarily lower PLP levels even when overall B6 stores are adequate, and conditions that affect the liver, kidneys, or albumin levels can all skew the results.

Researchers have identified a range of functional biomarkers that can supplement PLP measurement. These include the activity of certain enzymes in red blood cells and the levels of metabolites from B6-dependent chemical reactions, including compounds in the kynurenine pathway, one-carbon metabolism, and the transsulfuration pathway. A review of these biomarkers concluded that B6 status is best assessed using a combination of direct and functional markers, because any single measurement can be thrown off by confounders like inflammation, kidney function, and the activity of alkaline phosphatase.¹² In practice, most doctors order plasma PLP and interpret the result alongside the patient’s symptoms and other labs. The more sophisticated functional biomarkers tend to be reserved for research settings.

Effects on the Immune System

B6 deficiency does not just affect the nerves, blood, and skin. It also suppresses immune function. Animal research has demonstrated that B6 deficiency retards growth, inhibits the proliferation of lymphocytes (the white blood cells responsible for adaptive immunity), and interferes with their differentiation into the specific cell types needed to fight infections.¹³ This is consistent with B6’s role in amino acid metabolism: immune cells divide rapidly during an infection and need a steady supply of amino acids and the enzymes that process them.

There is also an inflammatory feedback loop to consider. Chronic inflammation, which accompanies conditions like autoimmune disease, obesity, and aging, independently lowers circulating PLP levels. Whether this represents true depletion (the body using up B6 to manage inflammation) or redistribution (B6 moving from the blood into tissues) is still debated. Either way, people with chronic inflammatory conditions are more likely to test low on standard B6 measures and may benefit from paying closer attention to their intake.

Homocysteine and Cardiovascular Risk

For years, elevated homocysteine was treated as a cardiovascular risk factor, and because B6 is one of the vitamins involved in recycling homocysteine, there was widespread hope that B6 supplementation could lower heart disease risk. The logic was clean: B6 deficiency raises homocysteine, high homocysteine damages blood vessels, so fixing B6 should protect the heart. The problem is that large clinical trials did not bear this out. A major trial found that supplements combining folic acid with vitamins B6 and B12 successfully lowered homocysteine levels but did not reduce the risk of major cardiovascular events in patients who already had vascular disease.¹⁴

This does not mean B6 is irrelevant to heart health, but it does mean that treating homocysteine as a simple cause-and-effect pathway was an oversimplification. Elevated homocysteine may be a marker of poor B-vitamin status rather than a direct cause of cardiovascular damage, or it may contribute to damage through pathways that supplementation alone cannot reverse once disease is established. The takeaway for most people is that maintaining adequate B6 through diet is a reasonable part of overall health, but megadosing B6 to chase a lower homocysteine number is unlikely to prevent heart attacks.

Pyridoxine-Dependent Epilepsy in Children

There is a rare genetic condition in which an infant’s seizures cannot be controlled with standard anti-epileptic drugs but respond dramatically to high-dose vitamin B6. Pyridoxine-dependent epilepsy has been studied for roughly seven decades. The most common form, called PDE-ALDH7A1, results from a deficiency in an enzyme involved in lysine metabolism rather than a deficiency of B6 itself. The genetic defect causes a toxic compound to accumulate that inactivates PLP, creating a localized B6 deficiency in the brain.¹⁵ Affected children need lifelong B6 supplementation at doses far above what would be recommended for the general population, and even with treatment, many experience some degree of developmental delay. Genetic testing can now confirm the diagnosis, which matters because early and aggressive treatment improves outcomes.

The Gut Microbiome’s Contribution

Your gut bacteria can synthesize B vitamins, including B6, and researchers are beginning to map just how much of the body’s B6 supply might come from microbial production rather than diet. A large-scale analysis of roughly 8,000 human gut microbiome samples found that the capacity for B-vitamin biosynthesis varied significantly based on host factors like age and geographical origin.¹⁶ This is still early-stage research, and nobody is suggesting that gut bacteria can replace dietary B6. But it opens the question of whether disruptions to the microbiome, from antibiotics, illness, or major dietary changes, could contribute to marginal B6 deficiency in ways that have not been fully accounted for. It also suggests that two people eating identical diets might have meaningfully different B6 status depending on the composition of their gut bacteria.

When to Actually Worry

Severe, isolated B6 deficiency is uncommon in people who eat a varied diet and do not have one of the conditions described above. The groups at real risk are specific: people with heavy alcohol use, those on hemodialysis, individuals with advanced liver disease, patients on certain medications (including isoniazid for tuberculosis, some antiepileptics, and, historically, high-dose oral contraceptives), and people who have had bariatric surgery. If you fall into one of these categories, it is worth asking your doctor about B6 monitoring, because the symptoms of deficiency, cracked lips, tingling hands, or fatigue, are common enough on their own that they are easy to attribute to something else.

For everyone else, the more practical concern is avoiding the trap of over-supplementation. The B6 paradox means that a well-intentioned person taking a high-potency B-complex supplement could inadvertently create the very symptoms they are trying to prevent. Sticking to food sources, or supplements that stay well under the upper limit, is the safer approach. And if you develop unexplained neuropathy symptoms while taking a B6 supplement, the first thing to do is check the dose on the label and stop taking it.